WallStreetZenWallStreetZen

NASDAQ: OBX
Obsidian Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Obsidian Therapeutics earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest OBX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$19.6M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OBX reported annual earnings of -$100.6M, with 21.1% growth.

OBX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

OBX Return on Equity

Insufficient data to display

OBX Return on Assets

Insufficient data to display

Be the first to know when OBX announces earnings.

OBX Return on Capital Employed

Current Company
0%
Current Industry
-9.6%

OBX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABVC-$7.88M-$8.63MN/A-$0.39
ABVX-$249.95M-$390.82MN/A-$5.28
ACET-$89.96M-$98.97MN/A-$10.46
ACXP-$7.50M-$7.50MN/A-$4.05
AARD-$69.47M-$69.87MN/A-$3.21
View Top Biotech Stocks

Obsidian Therapeutics Earnings Reports & History FAQ

What were Obsidian Therapeutics's earnings last quarter?

Obsidian Therapeutics (NASDAQ: OBX) reported Q1 2026 earnings per share (EPS) of -$1.11, up 37.99% year over year. Total OBX earnings for the quarter were -$19.63 million. In the same quarter last year, Obsidian Therapeutics's earnings per share (EPS) was -$1.79.

If you're new to stock investing, here's how to buy Obsidian Therapeutics stock.

Is Obsidian Therapeutics profitable or losing money?

As of the last Obsidian Therapeutics earnings report, Obsidian Therapeutics is currently losing money. Obsidian Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was OBX's earnings growth in the past year?

As of Obsidian Therapeutics's earnings date in Q3 2026, Obsidian Therapeutics's earnings has grown year over year. OBX earnings in the past year totalled N/A.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.